Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jerold Loh
Observed names:
J. Loh,
Jerold WZ Loh,
Loh, Jerold
Institution:
National University Cancer Institute, Singapore
Observed institutions:
National University Cancer Institute, Singapore,
National University Hospital,
National University Health System
ORCID:
0000-0003-1981-6221
Observed ORCID:
0000-0003-1981-6221
OpenAlex ID:
A5027629410
Four Patients with COVID-19 and Tuberculosis, Singapore, April–May 2020
2020
·
Sai Meng Tham
, Wei Yang Lim
, et al.
·
Emerging infectious diseases
·
53
PDF
Design and Multicenter Clinical Validation of a 3-Dimensionally Printed Nasopharyngeal Swab for SARS-CoV-2 Testing
2021
·
Joshua K. Tay
, Gail B. Cross
, et al.
·
JAMA Otolaryngology–Head & Neck Surgery
·
14
PDF
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience
2024
·
Silvana Talisa Wijaya
, Natalie YL Ngoi
, et al.
·
Journal of Gynecologic Oncology
·
13
PDF
Range of Varicella Zoster Co-Infections with COVID-19, Singapore
2021
·
Jerold Loh
, Sai Meng Tham
, et al.
·
Infection and Chemotherapy
·
10
DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study
2022
·
Zhiwei Xiao
, Lingling Sun
, et al.
·
Translational Lung Cancer Research
·
6
PDF
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials
2023
·
Jerold Loh
, Jiaxuan Wu
, et al.
·
British Journal of Cancer
·
5
PDF
Clinical characteristics and genetic testing outcome of suspected hereditary peripheral nerve sheath tumours in a tertiary cancer institution in Singapore
2022
·
Jerold Loh
, Pei Yi Ong
, et al.
·
Hereditary Cancer in Clinical Practice
·
5
PDF
Clinical Diagnostic Study of a Novel Injection Molded Swab for SARS-Cov-2 Testing
2021
·
Joshua K. Tay
, Gail B. Cross
, et al.
·
Infectious Diseases and Therapy
·
5
PDF
Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers—an Asian tertiary institution experience
2024
·
Victor Guan Hui Lee
, Jerold Loh
, et al.
·
Supportive Care in Cancer
·
4
PDF
Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer
2023
·
Jerold Loh
, Jia Li Low
, et al.
·
Expert Review of Anticancer Therapy
·
4
794P Efficacy of gemcitabine (gem) based therapy in ovarian clear cell carcinoma (OCCC)
2023
·
J. Loh
, N.Y.L. Ngoi
, et al.
·
Annals of Oncology
·
2
PDF
Resectable non-small cell lung cancer: an evolving landscape
2022
·
Jerold Loh
, Silvana T Wijaya
, et al.
·
Translational Lung Cancer Research
·
2
PDF
593P Role of circulating tumor DNA (ctDNA) in assessing primary anti–epidermal growth factor receptor (EGFR) resistance in untreated RAS/BRAF wild-type (WT) metastatic colorectal cancer (mCRC) patients (pts)
2023
·
J. Loh
, J. Choo
, et al.
·
Annals of Oncology
·
1
PDF
Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies
2022
·
Jerold Loh
, Yvonne Li En Ang
, et al.
·
JCO Precision Oncology
·
1
PDF
1077eP Treatment outcomes and EGFR mutation profiles in stage IV NSCLC patients with brain metastases: Insights from a Singapore cohort
2025
·
K.N. Tan
, I. Loh
, et al.
·
Annals of Oncology
279P External validation of the LORIS score for predicting immunotherapy response in a Asian patient cohort
2025
·
J. Loh
, C.K. Zhu
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
Corrigendum to “Chemotherapy response score (CRS) as a surrogate marker for homologous recombination deficiency (HRD) based on loss of heterozygosity (LOH) in high grade serous ovarian cancer (HGSOC) (165)” [Gynecologic Oncology Volume 166, Supplement 1, August 2022, Page S98]
2023
·
Silvana Wijaya
, Jerold Loh
, et al.
·
Gynecologic Oncology
PDF
Chemotherapy response score (CRS) as a surrogate marker for homologous recombination deficiency (HRD) based on loss of heterozygosity (LOH) in high grade serous ovarian cancer (HGSOC) (165)
2022
·
Silvana Wijaya
, Jerold Loh
, et al.
·
Gynecologic Oncology
Prognostic relevance of immune-related gene expression signatures (irGES) in patients (pts) with ovarian clear cell carcinomas (OCCC)
2017
·
V. Heong
, D. Lim
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
21
Citation count:
125
H-index:
5
I10-index:
4
Year
Topic
Type